Cellectis S.A. current report, Q2 FY2016

Cellectis S.A. Form 6-K Summary

Business Context and Reporting Period

This Form 6-K was filed by Cellectis S.A., a foreign private issuer headquartered in Paris, France, on May 23, 2016. The filing serves to distribute a press release dated May 23, 2016, to U.S. investors pursuant to Rule 13a-16 of the Securities Exchange Act of 1934.

Financial Metrics

The provided filing text does not contain specific financial data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity within this document.

Material Changes

The filing text does not provide information regarding material changes versus prior comparable periods.

Guidance, Outlook, and Risks

The filing references a press release (Exhibit 99.1) but does not include the text of that release. Consequently, no guidance, management commentary, risks, contingencies, or unusual items are detailed in the provided content.

Key Facts for Investor Verification

  • The filing is a procedural submission to distribute a press release dated May 23, 2016.
  • Specific financial results and operational details are not included in the Form 6-K text itself.
  • Investors must review the attached press release (Exhibit 99.1) to obtain the substantive information announced on this date.